Skip to main content Accessibility help
×
Hostname: page-component-78c5997874-s2hrs Total loading time: 0 Render date: 2024-11-18T21:52:57.819Z Has data issue: false hasContentIssue false

M

from Section 1 - Diagnostics

Published online by Cambridge University Press:  30 May 2019

Alan B. Ettinger
Affiliation:
Safe Passage Diagnostics, New York
Deborah M. Weisbrot
Affiliation:
State University of New York, Stony Brook
Casey E. Gallimore
Affiliation:
University of Wisconsin
Get access
Type
Chapter
Information
Publisher: Cambridge University Press
Print publication year: 2019

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss. Arch Ophthalmol. 2001; 119(10): 1417–36.Google Scholar
Schadlu, AP, Schadlu, R, Shepherd, JB. Charles Bonnet syndrome: a review. Curr Opin Ophthalmol. 2009: 20(3): 219–22.Google Scholar
American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-5. 5th ed. Washington, DC: American Psychiatric Association; 2013.Google Scholar
Beauregard, M, Paquette, V, Levesque, J. Dysfunction in the neural circuitry of emotional self-regulation in major depressive disorder. Neuroreport. 2006; 17(8): 843–6.CrossRefGoogle ScholarPubMed
Belmaker, RH, Agam, G. Major depressive disorder. New Engl J Med. 2008; 358(1): 5568.Google Scholar
Cotter, D, Mackay, D, Landau, S, Kerwin, R, Everall, I. Reduced glial cell density and neuronal size in the anterior cingulate cortex in major depressive disorder. Arch Gen Psychiatry. 2001; 58(6): 545–53.Google Scholar
Fava, M, Kendler, KS. Major depressive disorder. Neuron, 2000; 28(2): 335–41.Google Scholar
Holmes, AJ, Pizzagalli, DA. Spatiotemporal dynamics of error processing dysfunctions in major depressive disorder. Arch Gen Psychiatry. 2008; 65(2): 179–88.CrossRefGoogle ScholarPubMed
Lee, H, Halverson, S, Ezinwa, N. Mosquito-borne diseases. Prim Care. 2018; 45(3): 393407.Google Scholar
Salvana, EMT, Salata, RA, King, CH. Parasitic infections of the central nervous system. In Aminoff, MJ, Josephson, SA, eds. Aminoff's neurology and general medicine. 5th ed. London: Academic Press; 2014. pp. 947–51.Google Scholar
World Health Organization. World malaria report 2017. Geneva (Switzerland): World Health Organization; 2017.Google Scholar
American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-5. 5th ed. Washington, DC: American Psychiatric Association; 2013.Google Scholar
Meuleman, EJ, Van Lankveld, JJ. Hypoactive sexual desire disorder: An underestimated condition in men. BJU Int. 2005; 95(3): 291–6.Google Scholar
Segraves, KB, Segraves, RT. Hypoactive sexual desire disorder: Prevalence and comorbidity in 906 subjects. J Sex Marital Ther. 1991; 17(1): 55–8.Google Scholar
Stoléru, S, Redouté, J, Costes, N, et al. Brain processing of visual sexual stimuli in men with hypoactive sexual desire disorder. Psychiatry Res. 2003; 124(2): 6786.CrossRefGoogle ScholarPubMed
Rosenbaum, HK. Malignant hyperthermia. MedLink Neurology. Updated Jun 8, 2015. San Diego: MedLink Corporation. Available from www.medlink.com/article/malignant_hyperthermia. Accessed Aug 24, 2018.Google Scholar
American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-5. 5th ed. Washington, DC: American Psychiatric Association; 2013.Google Scholar
Mittenberg, W, Patton, C, Canyock, EM, Condit, DC. Base rates of malingering and symptom exaggeration. J Clin Exp Neuropsychol. 2002; 24(8): 1094–102.CrossRefGoogle ScholarPubMed
Pankratz, L, Erickson, RC. Two views of malingering. Clin Neuropsychol. 1990; 4(4): 379–89.Google Scholar
Rogers, R, ed. Clinical assessment of malingering and deception. New York: Guilford Press; 2008.Google Scholar
Stern, T, et al. Massachusetts General Hospital handbook of general hospital psychiatry. Philadephia, PA: Saunders; 2010.Google Scholar
Cersosimo, MG, Koller, WC. The diagnosis of manganese-induced parkinsonism. Neurotoxicology. 2006; 27(3): 340–6. PMID:16325915.Google Scholar
Chu, N-S, Huang, C-C, Calne, DB. Manganese. In Spencer, PS, Schaumburg, HH, eds. Experimental and clinical neurotoxicology. 2nd edition. Oxford, UK: Oxford University Press; 2000. pp. 752–5.Google Scholar
American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-5. 5th ed. Washington, DC: American Psychiatric Association; 2013.Google Scholar
McDonald, WM, Krishnan, KR, Doraiswamy, PM, et al. Occurrence of subcortical hyperintensities in elderly subjects with mania. Psychiatry Res. 1991; 40(4): 211–20.Google Scholar
Pares, P. Mania following deep brain stimulation for Parkinson's disease. Neurology. 2002; 59(9): 1421–4.Google Scholar
Peet, M. Induction of mania with selective serotonin re-uptake inhibitors and tricyclic antidepressants. Br J Psychiatry. 1994; 164(4): 549–50.Google Scholar
Starkstein, SE, Mayberg, HS, Berthier, ML, et al. Mania after brain injury: neuroradiological and metabolic findings. Ann Neurol. 1990; 27(6): 652–9.Google Scholar
Young, RC, Biggs, JT, Ziegler, VE, Meyer, DA. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry. 1978; 133(5): 429–35.CrossRefGoogle ScholarPubMed
Frazier, DM, et al. Nutrition management guideline for maple syrup urine disease: An evidence- and consensus-based approach. Mol Genet Metab. 2014; 112(3): 210–17.Google Scholar
NORD. Maple syprup urine disease. http://rarediseases.org/rare-diseases/maple-syrup-urine-disease/. Accessed Jun 20, 2016.Google Scholar
Strauss, KA, Puffenberger, EG, Morton, DH. Maple syrup urine disease. Jan 30, 2006. Updated May 9, 2013. In Pagon, RA, Adam, MP, Ardinger, HH, et al., eds. Gene Reviews®. Seattle (WA): University of Washington, Seattle; 1993–2016. Available from: https://www.ncbi.nlm.nih.gov/books/NBK1319/. Accessed Aug 25, 2018.Google Scholar
Ropper, AH, Samuels, MA, Klein, JP. Diseases of the nervous system caused by nutritional deficiency. In Adams & Victor's principles of neurology, 10th ed. New York, NY: McGraw-Hill; 2014. Chapter 41.Google Scholar
Rosa, A, Demiati, M, Cartz, L, Mizon, JP. Marchiafava-Bignami disease, syndrome of interhemispheric disconnection, and right-handed agraphia in a left-hander. Arch Neurol. 1991; 48: 986.Google Scholar
Marom, T, et al. Trends in otitis media-related health care utilization in the United States, 2001–2011. JAMA Pediatr. 2014; 168(1): 6875.Google Scholar
Wald, ER. Acute mastoiditis in children: Clinical features and diagnosis. In Post, TW, ed. UpToDate. Waltham, MA. Last updated Jan 3, 2017. https://www.uptodate.com/contents/acute-mastoiditis-in-children-clinical-features-and-diagnosis. Accessed Aug 25, 2018.Google Scholar
Centers for Disease Control and Prevention. Measles. In Hamborsky, J, et al., eds. Epidemiology and prevention of vaccine-preventable diseases (The Pink Book). 13th ed. Washington DC: Public Health Foundation; 2015. Chapter 13.Google Scholar
Gans, H, Maldonado, YA. Measles: Epidemiology and transmission. Last updated May 25, 2017. In Post, TW, ed. UpToDate. Waltham, MA. https://www.uptodate.com/contents/measles-epidemiology-and-transmission. Accessed Aug 25, 2018.Google Scholar
Moss, WJ, et al. Measles. The Lancet. 2012; 379(9811): 153–64.Google Scholar
Demicheli, V, Rivetti, A, Debalini, MG, Di Pietrantonj, C. Vaccines for measles, mumps and rubella in children. Cochrane Database Syst Rev. 2012: CD004407.Google Scholar
Elliman, D, Sengupta, N, El Bashir, H, Bedford, H. Measles, mumps, and rubella: prevention. BMJ Clin Evid. 2007; 2007: pii: 0316.Google Scholar
Hendriksz, T, Malouf, P, Foy, JE. Advisory Committee on Immunization Practices (ACIP) of the Centers for Disease Control and PreventionVaccines for measles, mumps, rubella, varicella, and herpes zoster: immunization guidelines for adults. J Am Osteopath Assoc. 2011; 111(10 Suppl 6): S10–2.Google Scholar
McLean, HQ, Fiebelkorn, AP, Temte, JL, et al. Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: summary recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2013; 62: 1.Google Scholar
White, SJ, Boldt, KL, Holditch, SJ, Poland, GA, Jacobson, RM. Measles, mumps, and rubella. Clin Obstet Gynecol. 2012; 55(2): 550–9. DOI: 10.1097/GRF.0b013e31824df256.Google Scholar
Kristoffersen, ES, Lundqvist, C. Medication-overuse headache: a review. J Pain Res. 2014; 7: 367–78. DOI: 10.2147/JPR.S46071.Google Scholar
Kudrow, L. Paradoxical effects of frequent analgesic use. Adv Neurol. 1982; 33: 335–41.Google Scholar
Mathew, NT, Kurman, R, Perez, F. Drug induced refractory headache: clinical features and management. Headache. 1990; 30(10): 634–8.Google Scholar
Mehuys, E, Paemeleire, K, Van Hees, T, et al. Self-medication of regular headache: a community pharmacy-based survey. Eur J Neurol. 2012; 19(8): 1093–9.Google Scholar
De Bont, JM, Packer, RJ, Michiels, EM, Den Boer, ML, Pieters, R. Biological background of pediatric medulloblastoma and ependymoma: a review from a translational research perspective. Neuro-oncology. 2008; 10(6): 1040–60.Google Scholar
Kieffer-Renaux, V, Bulteau, C, Grill, J, et al. Patterns of neuropsychological deficits in children with medulloblastoma according to craniospatial irradiation doses. Dev Med Child Neurol. 2000; 42(11): 741–5.Google Scholar
Taran, SJ, Taran, R, Malipatil, N, Haridas, K. Paediatric medulloblastoma: an updated review. West Indian Med J. 2016; 65(2): 363–8.Google ScholarPubMed
Balasubramaniam, R, Ram, S. Orofacial movement disorders. Oral Maxillofac Surg Clin North Am. 2008: 20(2): 273–85.Google Scholar
Colosimo, C, Suppa, A, Fabbrini, G, Bologna, M, Berardelli, A. Craniocervical dystonia: clinical and pathophysiological features. Eur J Neurol. 2010; 17(s1): 1521.Google Scholar
Kraft, SP, Lang, AE. Cranial dystonia, blepharospasm and hemifacial spasm: clinical features and treatment, including the use of botulinum toxin. CMAJ: Can Med Assoc J. 1988; 139(9): 837.Google Scholar
Choi, KN, Withers, HR, Rotman, M. Intracranial metastases from melanoma. Clinical features and treatment by accelerated fractionation. Cancer. 1985; 56(1): 19.Google Scholar
Hayward, RD. Malignant melanoma and the central nervous system. A guide for classification based on the clinical findings. J Neurol Neurosurg Psychiatr. 1976; 39(6): 526–30.Google Scholar
Raizer, JJ, Hwu, WJ, Panageas, KS, et al. Brain and leptomeningeal metastases from cutaneous melanoma: survival outcomes based on clinical features. Neuro-oncology. 2008; 10(2): 199207.Google Scholar
Harcourt, J, Barraclough, K, Bronstein, AM. Meniere's disease. BMJ. 2014; 349. PMID: 25391837.Google Scholar
Silverstein, H, Smouha, E, Jones, R. Natural history vs. surgery for Meniere's disease. Otolaryngol Head Neck Surg. 1989; 100: 616.Google Scholar
Wright, T. Menière's disease. BMJ Clin Evid. 2015; 2015: pii:0505. PMID: 26545070.Google Scholar
Gerganov, V, Bussarsky, V, Romansky, K, et al. Cerebellopontine angle meningiomas. Clinical features and surgical treatment. J Neurosurg Sci. 2003; 47(3): 129–35.Google Scholar
Jiang, XB, Ke, C, Han, ZA, et al. Intraparenchymal papillary meningioma of brainstem: case report and literature review. World J Surg Oncol. 2012; 10: 10.Google Scholar
Wofford, JL, Moran, WP, Wilson, TA, Velez, R. Clinical presentation of meningioma in the elderly. J Am Geriatr Soc. 1993; 41(2): 122–6.Google Scholar
Kaler, SG. ATP7A-related copper transport disorders. In Pagon, RA, Adam, MP, Ardinger, HH, et al., eds. Gene Reviews®. Updated Aug 18, 2016. Seattle, WA: University of Washington, Seattle; 1993–2017. Available from: https://www.ncbi.nlm.nih.gov/books/NBK1413/.Google Scholar
Tumer, Z, Moller, LB. Menkes disease. Eur J Hum Genet. 2010; 18: 511–18.Google Scholar
Cendes, F. Febrile seizures and mesial temporal sclerosis. Curr Opin Neurol. 2004; 17(2): 161–4.CrossRefGoogle ScholarPubMed
Garcia, CS. Depression in temporal lobe epilepsy: a review of prevalence, clinical features, and management considerations. Epilepsy Res Treat. 2012; 2012: 809843.Google Scholar
Lewis, DV. Losing neurons: selective vulnerability and mesial temporal sclerosis. Epilepsia. 2005; 46(Suppl 7): 3944.Google Scholar
Spano, VR, Mikulis, DJ. Mesial temporal sclerosis in epilepsy. CMAJ. 2011; 183(15): E1151.Google Scholar
Gustavson, KH, Hagberg, B. The incidence and genetics of metachromatic leucodystrophy in northern Sweden. Acta Paediatr Scand. 1971; 60: 585.Google Scholar
Heinisch, U, Zlotogora, J, Kafert, S, Gieselmann, V. Multiple mutations are responsible for the high frequency of metachromatic leukodystrophy in a small geographic area. Am J Hum Genet. 1995; 56: 51.Google Scholar
Holve, S, Hu, D, McCandless, SE. Metachromatic leukodystrophy in the Navajo: fallout of the American-Indian wars of the nineteenth century. Am J Med Genet. 2001; 101: 203.Google Scholar
Ropper, AH, Samuels, MA, Klein, JP. Inherited metabolic diseases of the nervous system. In Adams & Victor's principles of neurology, 10th ed. New York, NY: McGraw-Hill; 2014. Chapter 37.Google Scholar
Von Figura, K, Gieselmann, V, Jacken, J. Metachromatic leukodystrophy. In Scriver, CR, Beaudet, AL, Sly, WS, et al., eds. The metabolic and molecular bases of inherited diseases. 8th ed. New York: McGraw-Hill; 2001. p. 3695.Google Scholar
Zlotogora, J, Bach, G, Barak, Y, Elian, E. Metachromatic leukodystrophy in the habbanite Jews: high frequency in a genetic isolate and screening for heterozygotes. Am J Hum Genet. 1980 32: 663.Google Scholar
Ardakani, RK, Nahangi, H, Yadegari, M, Hosseini-Sharifabad, M. The effects of long-term administration of methamphetamine on the cerebellum of the male mice: a stereological study. The Neuroscience Journal of Shefaye Khatam. www.shefayekhatam.ir/browse.php?a_id=453&sid=1&slc_lang=en. Accessed Aug 28, 2018.Google Scholar
Foroughipour, M, Farzadfard, M, Aghaee, M, Ghabeli-Juibary, A, Rezaietalab, F. Methamphetamine related radiculopathy: case series and review of literature. Asia Pacific J Med Toxicol. 2013; 2(2): 71–5. DOI: 10.22038/apjmt.2013.894.Google Scholar
Gonzalez-Usigli, HA. Chorea, athetosis, and hemiballismus. MSD Manuals. Revised Feb 2017. Available from https://www.merckmanuals.com/professional/neurologic-disorders/movement-and-cerebellar-disorders/chorea,-athetosis,-and-hemiballismus. Accessed Aug 28, 2018.Google Scholar
NIDA. Methamphetamine. National Institute on Drug Abuse website. https://www.drugabuse.gov/publications/research-reports/methamphetamine. September 19, 2013. Accessed August 28, 2018.Google Scholar
Won, S, Hong, RA, Shohet, RV, Seto, TB, Parikh, NI. Methamphetamine-associated cardiomyopathy. Clin Cardiol. 2013; 36(12): 737–42. DOI: 10.1002/clc.22195.Google Scholar
Aminoff, MJ, Josephson, SA. Aminoff's neurology and general medicine. London, UK: Academic Press; 2014.Google Scholar
Jahnke, K, Korfel, A, Martus, P, et al. High-dose methotrexate toxicity in elderly patients with primary central nervous system lymphoma. Ann Oncol. 2005; 16(3): 445–9.Google Scholar
Wernick, R, Smith, DL. Central nervous system toxicity associated with weekly low-dose methotrexate treatment. Arthritis Rheum. 1989; 32(6): 770–5.Google Scholar
Warburg, M. Classification of microphthalmos and coloboma. J Med Genet. 1993; 30: 664–9.Google Scholar
Charles, A. Migraine: a brain state. Curr Opin Neurol. 2013; 26: 235–9.Google Scholar
Charles, A, Hansen, JM. Migraine aura: new ideas about cause, classification and clinical significance. Curr Opin Neurol. 2015; 28: 255–60.Google Scholar
Petrusic, I, Zidverc-Trajkovic, J. Cortical spreading depression; origins and paths as inferred from the sequence of events during migraine aura. Funct Neurol. 2014; 29: 207–12.Google Scholar
Reede, DL, Garcon, E, Smoker, WR, Kardon, R. Horner's syndrome: clinical and radiographic evaluation. Neuroimaging Clin N Am. 2008; 18(2): 369–85.Google Scholar
American Heart Association. Problem: mitral valve regurgitation. Feb 18, 2013. Available from www.heart.org/HEARTORG/Conditions/More/HeartValveProblemsandDisease/Problem-Mitral-Valve-Regurgitation_UCM_450612_Article.jsp. Accessed Jun 23, 2015.Google Scholar
Mayo Clinic Staff. Mitral valve regurgitation. Feb 18, 2015. Available from www.mayoclinic.org/diseases-conditions/mitral-valve-regurgitation/home/ovc-20121849. Accessed Jun 23, 2015.Google Scholar
Otto, CM, Bonow, RO. Valvular heart disease. In Mann, DL, Zipes, DP, Libby, P, Bonow, RO, Braunwald, E, eds. Braunwald's heart diseases: a textbook of cardiovascular medicine. 10th ed. Philadelphia: Elsevier/Saunders; 2015. pp. 1479–94.Google Scholar
American Heart Association. Problem: mitral valve stenosis. Aug 4, 2014. Available from www.heart.org/HEARTORG/Conditions/More/HeartValveProblemsandDisease/Problem-Mitral-Valve-Stenosis_UCM_450370_Article.jsp. Accessed Jun 23, 2015.Google Scholar
Mayo Clinic Staff. Mitral valve stenosis. Aug 22, 2014. Available from www.mayoclinic.org/diseases-conditions/mitral-valve-stenosis/basics/definition/con-20022582. Accessed Jun 23, 2015.Google Scholar
Otto, CM, Bonow, RO. Valvular heart disease. In Mann, DL, Zipes, DP, Libby, P, Bonow, RO, Braunwald, E, eds. Braunwald's heart diseases: a textbook of cardiovascular medicine. 10th ed. Philadelphia: Elsevier/Saunders; 2015. pp. 1469–79.Google Scholar
American Heart Association. Problem: mitral valve prolapse. Apr 24, 2015. Available from www.heart.org/HEARTORG/Conditions/More/HeartValveProblemsandDisease/Problem-Mitral-Valve-Prolapse_UCM_450441_Article.jsp. Accessed Jun 23, 2015.Google Scholar
Mayo Clinic Staff. Mitral valve prolapse. Apr 5, 2014. Available from www.mayoclinic.org/diseases-conditions/mitral-valve-prolapse/basics/definition/con-20024748. Accessed Jun 23, 2015.Google Scholar
Otto, CM, Bonow, RO. Valvular heart disease. In Mann, DL, Zipes, DP, Libby, P, Bonow, RO, Braunwald, E, eds. Braunwald's heart diseases: a textbook of cardiovascular medicine. 10th ed. Philadelphia: Elsevier/Saunders; 2015; pp. 14941497.Google Scholar
Farazmand, P, Woolley, PD, Kinghorn, GR. Mollaret's meningitis and HSV2 infections. Int J STD AIDS. 2011; 22(6): 306–7. DOI: 10.1258/ijsa.2010.010405.Google Scholar
Pearce, JMS. Mollaret's meningitis. Eur Neurol. 2008; 60: 316–17.Google Scholar
Poulikakos, PJ, Sergi, EE, Margaritas, AS, et al. A case of recurrent benign lymphocytic (Mollaret's) meningitis and review of the literature. J Infect Public Health. 2010; 3(4): 192–5. Copyright © 2010 King Saud Bin Abdulaziz University for Health Sciences.Google Scholar
Steel, JG, Dix, RD, Baringer, JR. Isolation of herpes simplex type 1 in recurrent (Mollarets) meningitis. Trans Am Neurol Assoc. 1981; 106: 3742.Google Scholar
Bindu, PS. Encephalopathy due to sulfite oxidase deficiency. Orphanet rare diseases portal. Updated Jan 2012. Available from www.orpha.net/consor/cgi-bin/OC_Exp.php?Expert=833. Accessed Aug 28, 2018.Google Scholar
Veldman, A, Santamaria-Araujo, JA, Sollazzo, S, et al. Successful treatment of molybdenum cofactor deficiency type A with cPMP. Pediatrics. 2010; 125(5): e1249–54. DOI: 10.1542/peds.2009–2192. Epub Apr 12, 2010.Google Scholar
Di Troia, A, Carpo, M, Meucci, N, et al. Clinical features and anti-neural reactivity in neuropathy associated with IgG monoclonal gammopathy of undetermined significance. J Neurol Sci. 1999; 164: 6471.Google Scholar
Nobile-Orazio, E, Manfredini, E, Carpo, M, et al. Frequency and clinical correlates of anti-neural IgM antibodies in neuropathy associated with IgM monoclonal gammopathy. Ann Neurol. 1994; 36: 416–24.Google Scholar
Grover, A, Clark-Bilodeau, C, D'Ambrosio, CM. Restless leg syndrome in pregnancy. Obstet Med. 2015; 8(3): 121–5.Google Scholar
Kranick, SM, Mowry, EM, Colcher, A, Horn, S, Golbe, LI. Movement disorders and pregnancy: a review of the literature. Mov Disord. 2010; 25(6): 665–71.Google Scholar
Manconi, M, Govoni, V, De Vito, A, et al. Pregnancy as a risk factor for restless legs syndrome. Sleep Med. 2004; 5(3): 305–8.Google Scholar
Pathania, M, Upadhayaya, S, Lali, BS, Sharma, A. Chorea gravidarum: a rarity in West still haunts pregnant women in the East. BMJ Case Rep. 2013; pii: bcr2012008096. DOI: 10.1136/bcr-2012-008096.Google Scholar
Robottom, BJ, Reich, SG. Exposure to high dosage trihexyphenidyl during pregnancy for treatment of generalized dystonia: case report and literature review. Neurologist. 2011; 17(6): 340–1.Google Scholar
Singhal, AB. Moyamoya disease. Medlink Neurology. Updated Dec 1, 2015. San Diego: MedLink Corporation. Available from www.medlink.com.Google Scholar
Centers for Disease Control and Prevention. Mucormycosis. Available from www.cdc.gov/fungal/diseases/mucormycosis/index.html. Accessed Aug 28, 2018.Google Scholar
Gonzalez, CE, Rinaldi, MG, Sugar, AM. Mucormycosis. Infect Dis Clin North Am. 2002; 16: 895914.Google Scholar
Petrikkos, G, Skiadda, A, Lortholary, O, et al. Epidemiology and clinical manifestations of mucormycosis. Clin Infect Dis. 2012; 4(suppl_1): S23S34.Google Scholar
Spellberg, B, Edwards, J Jr, Ibrahim, A. Novel perspectives on mucormycosis: pathophysiology, presentation, and management. Clin Microbiol Rev. 2005; 18(3): 556–69.Google Scholar
Katirji, B, Kaminski, HJ, Ruff, RL. Neuromuscular disorders in clinical practice. 2nd ed. New York: Springer-Verlag New York; 2014.Google Scholar
Katirji, B, Kaminski, HJ, Ruff, RL. Neuromuscular disorders in clinical practice. 2nd ed. New York: Springer-Verlag New York; 2014.Google Scholar
Hachinski, V. Optimizing the Hachinski Ischemic Scale. Arch Neurol. 2012; 69: 169–75.Google Scholar
Denier, C, Lozeron, P, Adams, D, et al. Multifocal neuropathy due to plasma cell infiltration of peripheral nerves in multiple myeloma. Neurology. 2006; 66(6): 917–8.Google Scholar
Dispenzieri, A, Kyle, RA. Neurological aspects of multiple myeloma and related disorders. Best Pract Res Clin Haematol. 2005; 18(4): 673–88.Google Scholar
Schluterman, KO, Fassas, AB, Van Hemert, RL, Harik, SI. Multiple myeloma invasion of the central nervous system. Arch Neurol. 2004; 61(9): 1423–9.CrossRefGoogle ScholarPubMed
Ropper, AH, Samuels, MA, Klein, JP. Multiple sclerosis and other inflammatory demyelinating diseases. In Adams & Victor's principles of neurology, 10th ed. New York, NY: McGraw-Hill; 2014. Chapter 36.Google Scholar
Alonso, A, Hernán, MA. Temporal trends in the incidence of multiple sclerosis: A systematic review. Neurology. 2008; 71(2): 129–35.Google Scholar
Alroughani, A, Altintas, A, Jumah, MA, et al. Pregnancy and the use of disease-modifying therapies in patients with multiple sclerosis: benefits versus risks. Mult Scler Int. 2016; 2016: 1034912.Google Scholar
Coyle, PK. Management of women with multiple sclerosis through pregnancy and after childbirth. Ther Adv Neurol Disord. 2016(3): 198210.Google Scholar
Jankovic, J, Rajput, AH, McDermott, MP, Perl, DP. The evolution of diagnosis in early Parkinson disease. Parkinson Study Group. Arch Neurol. 2000; 57(3): 369–72.Google Scholar
Dąbrowska, M, Schinwelski, M, Sitek, EJ, et al. The role of neuroimaging in the diagnosis of the atypical parkinsonian syndromes in clinical practice. Neurol Neurochir Pol. 2015; 49(6): 421–31.Google Scholar
Fanciulli, A, Wenning, GK. Multiple-system atrophy. NEJM. 2015; 372(3): 249–63.Google Scholar
Iodice, V, Lipp, A, Ahlskog, JE, et al. Autopsy confirmed multiple system atrophy cases: Mayo experience and role of autonomic function tests. J Neurol Neurosurg Psychiatry. 2012; 83: 453–9.Google Scholar
Köllensperger, M, Geser, F, Ndayisaba, JP, et al. Presentation, diagnosis, and management of multiple system atrophy in Europe: final analysis of the European multiple system atrophy registry. Mov Disord. 2010; 25(15): 2604–12.Google Scholar
Tada, M, Onodera, O, Tada, M, et al. Early development of autonomic dysfunction may predict poor prognosis in patients with multiple system atrophy. Arch Neurol. 2007; 64(2): 256–60.Google Scholar
Wenning, GK, Stefanova, N. Recent developments in multiple system atrophy. J Neurol. 2009; 256: 1791–808.Google Scholar
Fanciulli, A, Wenning, GK. Multiple-system atrophy. New Engl J Med. 2015; 372: 249–63.Google Scholar
Lin, DJ, Hermann, KL, Schmahmann, JD. Multiple system atrophy of the cerebellar type: Clinical state of the art. Mov Disord. 2014; 29(4): 294304.Google Scholar
Lin, IS, Wu, RM, Lee-Chen, GJ, Shan, DE, Gwinn-Hardy, K. The SCA17 phenotype can include features of MSA-C, PSP and cognitive impairment. Parkinsonism Relat Disord. 2007; 13(4): 246–9.Google Scholar
Wenning, GK, Stefanova, N. Recent developments in multiple system atrophy. J Neurol. 2009; 256: 1791–808.Google Scholar
Anderson, LJ, Seward, JF. Mumps epidemiology and immunity: the anatomy of a modern epidemic. Pediatr Infect Dis J. 2008; 27: S75.Google Scholar
Bruyn, HB, Sexton, HM, Brainerd, HD. Mumps meningoencephalitis: a clinical review of 119 cases with one death. Calif Med. 1957; 86(3): 153–60.Google Scholar
Centers for Disease Control and Prevention. Mumps cases and outbreaks. Updated June 27, 2018. https://www.cdc.gov/mumps/outbreaks.html. Accessed Apr 6, 2017.Google Scholar
Dourado, I, Cunha, S, Teixeira, MG et al. Outbreak of aseptic meningitis associated with mass vaccination with a urabe-containing measles-mumps-rubella vaccine: implications for immunization programs. Am J Epidemiol. 2000; 151(5): 524–30.Google Scholar
Johnstone, JA, Ross, CAC, Dunn, M. Meningitis and encephalitis associated with mumps infection: a 10-year survey. Arch Dis Child. 1972; 47(254): 647–51.Google Scholar
Mclean, DM, Bach, RD, Larke, RP, McNaughton, GA. Mumps meningoencephalitis, Toronto, 1963. Can Med Assoc J. 1964; 90: 458.Google Scholar
World Health Organization. Mumps reported cases. Jul 15, 2018. http://apps.who.int/immunization_monitoring/globalsummary/timeseries/tsincidencemumps.html. Accessed Sep 6, 2018.Google Scholar
Amato, AA, Russell, JA. Neuromuscular disorders. New York: McGraw-Hill; 2008. pp. 143–56Google Scholar
Longo, DL, Kasper, DL, Fauci, A, et al., eds. Harrison's principles of internal medicine. 17th ed. New York: McGraw-Hill Education/Medical; 2016. pp. 1292, 1412, 1462–4.Google Scholar
Amato, AA, Russell, JA. Neuromuscular disorders. 2nd ed. New York: McGraw-Hill Medical; 2016.Google Scholar
Katirji, B, Kaminski, HJ, Ruff, RL. Neuromuscular disorders in clinical practice. 2nd ed. New York: Springer-Verlag New York; 2014.Google Scholar
Chaudhry, SA, Vignarajah, B, Koren, G. Myasthenia gravis during pregnancy. Can Fam Physician. 2012; 58(12): 1346–9.Google Scholar
Sanders, DB, Wolfe, GI, Benatar, M, et al. International consensus guidance for management of myasthenia gravis: Executive summary. Neurology. 2016; 87(4): 419–25.Google Scholar
Wolfe, GI, Kaminski, HJ, Aban, IB, et al.; MGTX Study Group. Randomized trial of thymectomy in myasthenia gravis. N Engl J Med. 2016; 375(6): 511–22.Google Scholar
Bitnun, A, Ford-Jones, E, Blaser, S, Richardson, S. Mycoplasma pneumoniae encephalitis. Semin Pediatr Infect Dis. 2003; 14: 96.Google Scholar
Daxboeck, F. Mycoplasma pneumoniae central nervous system infections. Curr Opin Neurol. 2006; 19: 374.Google Scholar
Foy, HM, Kenny, GE, Cooney, MK, Allan, ID. Long-term epidemiology of infections with Mycoplasma pneumoniae. J Infect Dis. 1979; 139: 681.Google Scholar
Gücüyener, K, Simşek, F, Yilmaz, O, et al. Methyl-prednisolone in neurologic complications of Mycoplasma pneumonia. Indian J Pediatr. 2000; 67(6): 467–9.Google Scholar
Tsiodras, S, Kelesidis, T, Kelesidis, I, et al. Mycoplasma pneumoniae-associated myelitis: a comprehensive review. Eur J Neurol. 2006; 13: 112.Google Scholar
Chun, JY, Smith, W, Halbach, VV, et al. Current multimodality management of infectious intracranial aneurysms. Neurosurgery. 2001; 48(6): 1203–13; discussion 1213–4.Google Scholar
Mandell, G. Infective endarteritis and mycotic aneurysms. In Mandell, G, Bennett, J, Dolin, R, eds. Principles and practice of infectious disease. Philadelphia: Churchill Livingstone; 2000. pp. 888–92.Google Scholar
American Heart Association. About heart attacks. May 15, 2015. Available from www.heart.org/HEARTORG/Conditions/HeartAttack/AboutHeartAttacks/About-Heart-Attacks_UCM_002038_Article.jsp. Accessed Jun 23, 2015.Google Scholar
Mayo Clinic Staff. Heart attack. Nov 15, 2014. Available from www.mayoclinic.org/diseases-conditions/heart-attack/basics/definition/con-20019520. Accessed Jun 23, 2015.Google Scholar
Scirica, BM, Morrow, DA. ST-elevation myocardial infarction: pathology, pathophysiology, and clinical features. In Mann, DL, Zipes, D, Libby, P, Bonow, RO, Braunwald, E, eds. Braunwald's heart disease: A textbook of cardiovascular medicine. 10th ed. Philadelphia, PA: Elsevier/Saunders; 2015; pp. 1071–85.Google Scholar
Amato, AA, Russell, JA. Neuromuscular disorders. New York: McGraw-Hill; 2008. pp. 143–56.Google Scholar
DiMauro, S, Hirano, M. MERRF. GeneReviews®. Jun 3, 2003. Updated Jan 29, 2015. Seattle (WA): University of Washington, Seattle; 19932017.Google Scholar
Tobon, A. Metabolic myopathies. Continuum (Minneap Minn). 2013; 19(6 Muscle Disease): 1571–97.Google Scholar
Hess, CW, Raymond, D, Aguiar Pde, C, Frucht, S, et al. Myoclonus-dystonia, obsessive-compulsive disorder, and alcohol dependence in SGCE mutation carriers. Neurology. 2007; 68: 522–4.Google Scholar
Kinugawa, K, Vidailhet, M, Clot, F, et al. Myoclonus-dystonia: An update. Mov Disord. 2009; 24: 479–89.Google Scholar
Raymond, D, Ozelius, L. Myoclonus-dystonia. May 21, 2003. Updated Jan 26, 2012. In Pagon, RA, Adam, MP, Ardinger, HH, et al., eds. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 19932016.Google Scholar
Zimprich, A, Grabowski, M, Asmus, F, et al. Mutations in the gene encoding epsilon-sarcoglycan cause myoclonus-dystonia syndrome. Nat Genet. 2001; 29: 66–9.Google Scholar
Goldstein, J, Austin, S, Kishnani, P, et al. Phosphorylase kinase deficiency. May 31, 2011. In Pagon, RA, Adam, MP, Ardinger, HH, et al., eds. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 19932016.Google Scholar
Luica, A, Nogales-Gadea, G, Pérez, M, et al. McArdle disease – what do neurologists need to know? Nat Clin Pract Neurol. 2008; 4(10): 568–77. DOI: 10.1038/ncpneuro0913Google Scholar
Martín, MA, Lucía, A, Arenas, J, et al. Glycogen storage disease type V. Apr 19, 2006. Updated Jun 26, 2014. In Pagon, RA, Adam, MP, Ardinger, HH, et al., eds. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 19932016.Google Scholar
Udd, B. The myotonic dystrophies: molecular, clinical, and therapeutic challenges. Lancet Neurol. 2012; 11(10): 891905.Google Scholar
Wicklund, MP. The muscular dystrophies. Continuum (Minneap Minn). 2013; 19(6): 1535–70.Google Scholar
Udd, B. The myotonic dystrophies: molecular, clinical, and therapeutic challenges. Lancet Neurol. 2012; 11(10): 891905.Google Scholar
Wicklund, MP. The muscular dystrophies. Continuum (Minneap Minn). 2013; 19(6): 1535–70.Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×